The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-reported outcomes from randomized, phase-3 study of trabectedin (T) vs. dacarbazine (D) in advanced leiomyosarcoma (LMS) or liposarcoma (LPS).
 
George D. Demetri
Leadership - Blueprint Medicines
Stock and Other Ownership Interests - Bessor Pharma; Blueprint Medicines; Caris Life Sciences; Champions Oncology; G1 Therapeutics; Kolltan Pharmaceuticals; N-of-One
Consulting or Advisory Role - Adaptimmune; ARIAD; Bayer; Blueprint Medicines; Caris Life Sciences; Daiichi Sankyo; EMD Serono; G1 Therapeutics; Genocea Biosciences; Janssen Oncology; Kolltan Pharmaceuticals; Kyocera; Lilly; Nektar; Novartis; Pfizer; PharmaMar; Polaris; Sanofi; WIRB-Copernicus Group; ZIOPHARM Oncology
Research Funding - Abbvie (Inst); Amgen (Inst); Bayer (Inst); Eisai (Inst); Janssen Oncology (Inst); Novartis (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Patent on use of imatinib for GIST, receive minor royalty payment from Dana-Farber after license between Dana-Farber and Novartis
 
Margaret von Mehren
Consulting or Advisory Role - Blueprint Medicines; CytRx Corporation; Eisai; Janssen Oncology
Research Funding - ArQule
Travel, Accommodations, Expenses - ARIAD; Blueprint Medicines; Eisai; Janssen Oncology; Novartis
 
Robin Lewis Jones
Honoraria - Compass Oncology; EMD Serono; IMS Health; Novartis; Pfizer; The Dominion Group
Consulting or Advisory Role - Compass Oncology; EMD Serono; IMS Health; Novartis; Pfizer; The Dominion Group
Research Funding - Bayer (Inst); Eisai (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Infinity Pharmaceuticals (Inst); Janssen Research & Development (Inst); MabVax (Inst); Merck Sharp & Dohme (Inst); Morphotek (Inst); Novartis (Inst); PharmaMar (Inst); Threshold Pharmaceuticals (Inst); Ziopharm Oncology (Inst)
Travel, Accommodations, Expenses - Compass Oncology; EMD Serono; Novartis; Pfizer; PharmaMar
 
Martee Leigh Hensley
Employment - Sanofi (I)
Consulting or Advisory Role - EMD Serono; Insys Therapeutics
Research Funding - Johnson & Johnson (Inst)
Patents, Royalties, Other Intellectual Property - author, Up to Date
 
Scott Schuetze
Honoraria - EMD Serono; EMD Serono; Janssen Research & Development
Consulting or Advisory Role - EMD Serono; EMD Serono; Janssen Research & Development
Research Funding - AB Science (Inst); Amgen (Inst); BioMed Valley Discoveries (Inst); CytRx Corporation (Inst); Janssen Research & Development (Inst); Plexxikon (Inst); Threshold Pharmaceuticals (Inst); ZIOPHARM Oncology (Inst)
Travel, Accommodations, Expenses - Amgen; BioMed Valley Discoveries; EMD Serono; Janssen Research & Development; Lilly
 
Anthony D. Elias
Consulting or Advisory Role - Genentech
Research Funding - Astellas Pharma (Inst); CytRx Corporation (Inst); Eisai (Inst); Eisai (Inst); Genentech (Inst); ImClone Systems (Inst); Incyte (Inst); Johnson & Johnson (Inst); Medivation (Inst)
Travel, Accommodations, Expenses - Genentech
 
Renee F. Pierson
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Roland Elmar Knoblauch
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Youn C. Park
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
George C. Wang
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Nushmia Z. Khokhar
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Robert G Maki
Consulting or Advisory Role - Janssen Research & Development
Research Funding - Janssen Research & Development (Inst)
 
Shreyaskumar Patel
Consulting or Advisory Role - CytRx Corporation; Daiichi Sankyo; EMD Serono; Johnson & Johnson; Novartis
Research Funding - Eisai (Inst); Johnson & Johnson (Inst); Morphotek (Inst); PharmaMar (Inst)
 
Charles S. Cleeland
Honoraria - Lilly; Merck; Merck Sharp & Dohme; Onconova Therapeutics; Pfizer
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck; Merck Sharp & Dohme; Novartis; Onconova Therapeutics; Pfizer
Research Funding - Bayer (Inst); Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Bayer License agreement to use the MDASI (M D Anderson Symptom Inventory) (Inst)
Travel, Accommodations, Expenses - Lilly; Merck; Merck Sharp & Dohme; Onconova Therapeutics; Pfizer